On Invalid Date, Nuvation Bio (NYSE: NUVB) reported Q4 2023 earnings per share (EPS) of -$0.07, up 22.22% year over year. Total Nuvation Bio earnings for the quarter were -$13.79 million. In the same quarter last year, Nuvation Bio's earnings per share (EPS) was -$0.09.
As of Q2 2024, Nuvation Bio's earnings has grown year over year. Nuvation Bio's earnings in the past year totalled -$75.80 million.
What is NUVB's earnings date?
Nuvation Bio's earnings date is Invalid Date. Add NUVB to your watchlist to be reminded of NUVB's next earnings announcement.
What was NUVB's revenue last quarter?
On Invalid Date, Nuvation Bio (NYSE: NUVB) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Nuvation Bio's revenue was $0.00.
What was NUVB's revenue growth in the past year?
As of Q2 2024, Nuvation Bio's revenue has grown null year over year. Nuvation Bio's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.